Nasopharyngeal carcinoma

Evidence for improved survival with combined chemoradiation

Timothy Smith, Douglas C. DiRugguero, Mark C. Weissler

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Radiation therapy has been the traditional treatment for nasopharyngeal carcinoma. Patients with advanced disease have a higher rate of locoregional as well as distant metastases, which has warranted the addition of chemotherapy in an attempt to improve survival. This retrospective study was designed to determine the absolute survival of patients with nasopharyngeal cancer treated with radiation alone, compared to that of patients receiving concurrent chemoradiation. Between December 1975 and December 1993 eight patients were treated with radiotherapy alone and 14 patients were treated with concurrent chemoradiation using 5-fluorouracil and cisplatin. Analysis of Kaplan-Meier cumulative absolute survival plots revealed that patients receiving chemoradiation survived longer than those receiving radiation alone (p=0.0321). Patients with lymphoepithelioma, as opposed to squamous cell carcinoma, and patients younger than 30 years were also found to have longer survival, although these differences were not statistically significant (p=0.0913 and p=0.04044, respectively).

Original languageEnglish (US)
Pages (from-to)484-489
Number of pages6
JournalEar, Nose and Throat Journal
Volume77
Issue number6
StatePublished - Jun 1998
Externally publishedYes

Fingerprint

Survival
Radiotherapy
Radiation
Nasopharyngeal Neoplasms
Nasopharyngeal carcinoma
Kaplan-Meier Estimate
Fluorouracil
Cisplatin
Squamous Cell Carcinoma
Retrospective Studies
Neoplasm Metastasis
Drug Therapy
Therapeutics

ASJC Scopus subject areas

  • Otorhinolaryngology

Cite this

Nasopharyngeal carcinoma : Evidence for improved survival with combined chemoradiation. / Smith, Timothy; DiRugguero, Douglas C.; Weissler, Mark C.

In: Ear, Nose and Throat Journal, Vol. 77, No. 6, 06.1998, p. 484-489.

Research output: Contribution to journalArticle

Smith, Timothy ; DiRugguero, Douglas C. ; Weissler, Mark C. / Nasopharyngeal carcinoma : Evidence for improved survival with combined chemoradiation. In: Ear, Nose and Throat Journal. 1998 ; Vol. 77, No. 6. pp. 484-489.
@article{f0b0aa44b00c415c958ddb1fe72ac0a7,
title = "Nasopharyngeal carcinoma: Evidence for improved survival with combined chemoradiation",
abstract = "Radiation therapy has been the traditional treatment for nasopharyngeal carcinoma. Patients with advanced disease have a higher rate of locoregional as well as distant metastases, which has warranted the addition of chemotherapy in an attempt to improve survival. This retrospective study was designed to determine the absolute survival of patients with nasopharyngeal cancer treated with radiation alone, compared to that of patients receiving concurrent chemoradiation. Between December 1975 and December 1993 eight patients were treated with radiotherapy alone and 14 patients were treated with concurrent chemoradiation using 5-fluorouracil and cisplatin. Analysis of Kaplan-Meier cumulative absolute survival plots revealed that patients receiving chemoradiation survived longer than those receiving radiation alone (p=0.0321). Patients with lymphoepithelioma, as opposed to squamous cell carcinoma, and patients younger than 30 years were also found to have longer survival, although these differences were not statistically significant (p=0.0913 and p=0.04044, respectively).",
author = "Timothy Smith and DiRugguero, {Douglas C.} and Weissler, {Mark C.}",
year = "1998",
month = "6",
language = "English (US)",
volume = "77",
pages = "484--489",
journal = "Ear, Nose and Throat Journal",
issn = "0145-5613",
publisher = "Medquest Communications LLC",
number = "6",

}

TY - JOUR

T1 - Nasopharyngeal carcinoma

T2 - Evidence for improved survival with combined chemoradiation

AU - Smith, Timothy

AU - DiRugguero, Douglas C.

AU - Weissler, Mark C.

PY - 1998/6

Y1 - 1998/6

N2 - Radiation therapy has been the traditional treatment for nasopharyngeal carcinoma. Patients with advanced disease have a higher rate of locoregional as well as distant metastases, which has warranted the addition of chemotherapy in an attempt to improve survival. This retrospective study was designed to determine the absolute survival of patients with nasopharyngeal cancer treated with radiation alone, compared to that of patients receiving concurrent chemoradiation. Between December 1975 and December 1993 eight patients were treated with radiotherapy alone and 14 patients were treated with concurrent chemoradiation using 5-fluorouracil and cisplatin. Analysis of Kaplan-Meier cumulative absolute survival plots revealed that patients receiving chemoradiation survived longer than those receiving radiation alone (p=0.0321). Patients with lymphoepithelioma, as opposed to squamous cell carcinoma, and patients younger than 30 years were also found to have longer survival, although these differences were not statistically significant (p=0.0913 and p=0.04044, respectively).

AB - Radiation therapy has been the traditional treatment for nasopharyngeal carcinoma. Patients with advanced disease have a higher rate of locoregional as well as distant metastases, which has warranted the addition of chemotherapy in an attempt to improve survival. This retrospective study was designed to determine the absolute survival of patients with nasopharyngeal cancer treated with radiation alone, compared to that of patients receiving concurrent chemoradiation. Between December 1975 and December 1993 eight patients were treated with radiotherapy alone and 14 patients were treated with concurrent chemoradiation using 5-fluorouracil and cisplatin. Analysis of Kaplan-Meier cumulative absolute survival plots revealed that patients receiving chemoradiation survived longer than those receiving radiation alone (p=0.0321). Patients with lymphoepithelioma, as opposed to squamous cell carcinoma, and patients younger than 30 years were also found to have longer survival, although these differences were not statistically significant (p=0.0913 and p=0.04044, respectively).

UR - http://www.scopus.com/inward/record.url?scp=0031843495&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031843495&partnerID=8YFLogxK

M3 - Article

VL - 77

SP - 484

EP - 489

JO - Ear, Nose and Throat Journal

JF - Ear, Nose and Throat Journal

SN - 0145-5613

IS - 6

ER -